Biocept (NASDAQ:BIOC) reported its Q4 earnings results on Wednesday, April 6, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Biocept beat estimated earnings by 5.26%, reporting an EPS of $-0.18 versus an estimate of $-0.19.
Revenue was down $4.54 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 2.51% drop in the share price the next day.
Here's a look at Biocept's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.06 | -0.27 | ||
| EPS Actual | 0.03 | -0.14 | 0.19 | 0.14 |
| Revenue Estimate | 16.07M | 17.76M | 13.67M | 12.32M |
| Revenue Actual | 17.47M | 12.05M | 17.76M | 18.51M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
